US Patent 11701326 Amlodipine formulations
Patent 11701326 was granted and assigned to Azurity Pharmaceuticals on July, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 7 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 Jul, 2023
Golden AI
Edits made to:
Infobox (+26 properties)
Article (+227 characters)
US Patent 11701326 Amlodipine formulations
Article
Provided herein are stable amlodipine liquid formulations. Also provided herein are methods of using amlodipine liquid formulations for the treatment of certain diseases including hypertension and Coronary Artery Disease (CAD).
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
117013260
Date of Patent
July 18, 2023
0Patent Application Number
178927380
Date Filed
August 22, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11701326 Amlodipine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.